New homoisoflavonoid analogues protect cells by regulating autophagy
A series of homoisoflavonoid derivatives were designed and synthesized for the development of drug candidates for cell protective activities. [Display omitted] As a special group of naturally occurring flavonoids, homoisoflavonoids have been discovered as active components of several traditional Chi...
Saved in:
Published in | Bioorganic & medicinal chemistry letters Vol. 27; no. 6; pp. 1441 - 1445 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
OXFORD
Elsevier Ltd
15.03.2017
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A series of homoisoflavonoid derivatives were designed and synthesized for the development of drug candidates for cell protective activities.
[Display omitted]
As a special group of naturally occurring flavonoids, homoisoflavonoids have been discovered as active components of several traditional Chinese medicines for nourishing heart and mind. In this study, twenty homoisoflavonoid analogues, including different substitution groups on rings A and B, as well as heteroaromatic B ring, were synthesized and evaluated for their cardioprotective and neuroprotective activities. In a H2O2-induced H9c2 cardiomyocytes injury assay, nine homoisoflavonoid analogues showed promising activities in the same level as the positive control, diazoxide. Six cardioprotective compounds with representative structure diversities were then evaluated for their neuroprotective effects on MPP+ induced SH-SY5Y cell injury model. Furthermore, autophagy inducing monodansylcadaverine (MDC) fluorescence staining methods and molecular docking studies indicated the action mechanism of these compounds may involve autophagy regulating via class I PI3K signaling pathway. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2017.01.086 |